Para Advisors’s Amedisys AMED Stock Holding History

Para Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-125,000	Closed	-$2.15M	–	28
2013 Q3	$2.15M	Buy	+125,000	New	+$1.85M	1.54%	20

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Para Advisors's AMED Position: Q4 2013 in Review

Para Advisors sold out of Amedisys (AMED) in Q4 2013, closing a stake of 125,000 shares — an estimated $2.15M sold.

Para Advisors first reported a position in AMED in Q3 2013 and held it in 1 quarter. The position peaked at $2.15M in Q3 2013. 124 funds tracked by Wall St. Rank hold AMED as of Q4 2013.

Para Advisors reported no remaining Amedisys position as of Q4 2013 after selling out during the quarter.
Para Advisors sold 125,000 Amedisys shares in Q4 2013, an estimated $2.15M.
Para Advisors first reported a position in Amedisys in Q3 2013 and held it in 1 quarter.
Para Advisors's Amedisys position peaked at $2.15M in Q3 2013.
124 funds tracked by Wall St. Rank held Amedisys as of Q4 2013.

Based on Para Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.